4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-041809
General Counsel sold 368 shares at $0.77 ($284)
From the SEC's structured data for this filing
Trades in this filing
Miller Edward · General Counsel
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-02 | Sale : show line 1 in the form | −368 | $0.77 | $284 | 224,610 | D |
| Open-market sales · 368 sh · avg $0.77 · $284 | ||||||
Loading xslF345X05/ownership.xml…